These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
204 related articles for article (PubMed ID: 36918534)
1. Structural dynamics in the evolution of SARS-CoV-2 spike glycoprotein. Calvaresi V; Wrobel AG; Toporowska J; Hammerschmid D; Doores KJ; Bradshaw RT; Parsons RB; Benton DJ; Roustan C; Reading E; Malim MH; Gamblin SJ; Politis A Nat Commun; 2023 Mar; 14(1):1421. PubMed ID: 36918534 [TBL] [Abstract][Full Text] [Related]
2. A bias of Asparagine to Lysine mutations in SARS-CoV-2 outside the receptor binding domain affects protein flexibility. Boer JC; Pan Q; Holien JK; Nguyen TB; Ascher DB; Plebanski M Front Immunol; 2022; 13():954435. PubMed ID: 36569921 [TBL] [Abstract][Full Text] [Related]
3. SARS-CoV-2 Spike Protein Is Capable of Inducing Cell-Cell Fusions Independent from Its Receptor ACE2 and This Activity Can Be Impaired by Furin Inhibitors or a Subset of Monoclonal Antibodies. Reuter N; Chen X; Kropff B; Peter AS; Britt WJ; Mach M; Überla K; Thomas M Viruses; 2023 Jul; 15(7):. PubMed ID: 37515187 [TBL] [Abstract][Full Text] [Related]
4. Omicron: A Heavily Mutated SARS-CoV-2 Variant Exhibits Stronger Binding to ACE2 and Potently Escapes Approved COVID-19 Therapeutic Antibodies. Shah M; Woo HG Front Immunol; 2021; 12():830527. PubMed ID: 35140714 [TBL] [Abstract][Full Text] [Related]
5. SARS-CoV-2 variants impact RBD conformational dynamics and ACE2 accessibility. Valério M; Borges-Araújo L; Melo MN; Lousa D; Soares CM Front Med Technol; 2022; 4():1009451. PubMed ID: 36277437 [TBL] [Abstract][Full Text] [Related]
6. Understanding the Driving Forces That Trigger Mutations in SARS-CoV-2: Mutational Energetics and the Role of Arginine Blockers in COVID-19 Therapy. Ridgway H; Chasapis CT; Kelaidonis K; Ligielli I; Moore GJ; Gadanec LK; Zulli A; Apostolopoulos V; Mavromoustakos T; Matsoukas JM Viruses; 2022 May; 14(5):. PubMed ID: 35632769 [TBL] [Abstract][Full Text] [Related]
7. Structural diversity of the SARS-CoV-2 Omicron spike. Gobeil SM; Henderson R; Stalls V; Janowska K; Huang X; May A; Speakman M; Beaudoin E; Manne K; Li D; Parks R; Barr M; Deyton M; Martin M; Mansouri K; Edwards RJ; Eaton A; Montefiori DC; Sempowski GD; Saunders KO; Wiehe K; Williams W; Korber B; Haynes BF; Acharya P Mol Cell; 2022 Jun; 82(11):2050-2068.e6. PubMed ID: 35447081 [TBL] [Abstract][Full Text] [Related]
9. Omicron SARS-CoV-2 mutations stabilize spike up-RBD conformation and lead to a non-RBM-binding monoclonal antibody escape. Zhao Z; Zhou J; Tian M; Huang M; Liu S; Xie Y; Han P; Bai C; Han P; Zheng A; Fu L; Gao Y; Peng Q; Li Y; Chai Y; Zhang Z; Zhao X; Song H; Qi J; Wang Q; Wang P; Gao GF Nat Commun; 2022 Aug; 13(1):4958. PubMed ID: 36002453 [TBL] [Abstract][Full Text] [Related]
10. Dynamics of SARS-CoV-2 Spike Proteins in Cell Entry: Control Elements in the Amino-Terminal Domains. Qing E; Kicmal T; Kumar B; Hawkins GM; Timm E; Perlman S; Gallagher T mBio; 2021 Aug; 12(4):e0159021. PubMed ID: 34340537 [TBL] [Abstract][Full Text] [Related]
11. Probing structural basis for enhanced binding of SARS-CoV-2 P.1 variant spike protein with the human ACE2 receptor. Lata S; Akif M J Cell Biochem; 2022 Jul; 123(7):1207-1221. PubMed ID: 35620980 [TBL] [Abstract][Full Text] [Related]
12. Impact of Genetic Variability in ACE2 Expression on the Evolutionary Dynamics of SARS-CoV-2 Spike D614G Mutation. Huang SW; Miller SO; Yen CH; Wang SF Genes (Basel); 2020 Dec; 12(1):. PubMed ID: 33374416 [TBL] [Abstract][Full Text] [Related]
13. SARS-CoV-2's Variants of Concern: A Brief Characterization. Scovino AM; Dahab EC; Vieira GF; Freire-de-Lima L; Freire-de-Lima CG; Morrot A Front Immunol; 2022; 13():834098. PubMed ID: 35958548 [TBL] [Abstract][Full Text] [Related]
14. Omicron and Delta variant of SARS-CoV-2: A comparative computational study of spike protein. Kumar S; Thambiraja TS; Karuppanan K; Subramaniam G J Med Virol; 2022 Apr; 94(4):1641-1649. PubMed ID: 34914115 [TBL] [Abstract][Full Text] [Related]
15. Significance of the RBD mutations in the SARS-CoV-2 omicron: from spike opening to antibody escape and cell attachment. Hossen ML; Baral P; Sharma T; Gerstman B; Chapagain P Phys Chem Chem Phys; 2022 Apr; 24(16):9123-9129. PubMed ID: 35395667 [TBL] [Abstract][Full Text] [Related]
16. SARS-CoV-2 vaccine breakthrough infections (VBI) by Omicron variant (B.1.1.529) and consequences in structural and functional impact. Abduljaleel Z; Melebari S; Athar M; Dehlawi S; Udhaya Kumar S; Aziz SA; Dannoun AI; Malik SM; Thasleem J; George Priya Doss C Cell Signal; 2023 Sep; 109():110798. PubMed ID: 37423342 [TBL] [Abstract][Full Text] [Related]
17. Characterization of SARS-CoV-2 Variants B.1.617.1 (Kappa), B.1.617.2 (Delta), and B.1.618 by Cell Entry and Immune Evasion. Ren W; Ju X; Gong M; Lan J; Yu Y; Long Q; Kenney DJ; O'Connell AK; Zhang Y; Zhong J; Zhong G; Douam F; Wang X; Huang A; Zhang R; Ding Q mBio; 2022 Apr; 13(2):e0009922. PubMed ID: 35266815 [TBL] [Abstract][Full Text] [Related]
18. SARS-CoV-2 Variants Increase Kinetic Stability of Open Spike Conformations as an Evolutionary Strategy. Yang Z; Han Y; Ding S; Shi W; Zhou T; Finzi A; Kwong PD; Mothes W; Lu M mBio; 2021 Feb; 13(1):e0322721. PubMed ID: 35164561 [TBL] [Abstract][Full Text] [Related]
19. Evolution of SARS-CoV-2 Spikes shapes their binding affinities to animal ACE2 orthologs. Yao W; Li Y; Ma D; Hou X; Wang H; Tang X; Cheng D; Zhang H; Du C; Pan H; Li C; Lin H; Sun M; Ding Q; Wang Y; Gao J; Zhong G Microbiol Spectr; 2023 Dec; 11(6):e0267623. PubMed ID: 37943512 [TBL] [Abstract][Full Text] [Related]
20. In Silico Genome Analysis Reveals the Evolution and Potential Impact of SARS-CoV-2 Omicron Structural Changes on Host Immune Evasion and Antiviral Therapeutics. Chauhan D; Chakravarty N; Jeyachandran AV; Jayakarunakaran A; Sinha S; Mishra R; Arumugaswami V; Ramaiah A Viruses; 2022 Nov; 14(11):. PubMed ID: 36366559 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]